| Robert B Rebhun- BS, DVM, PhD
Assistant Professor and Assistant Research Scientist
Surgical & Radiological Sciences
217 CCAH
Davis, CA 95616 +1 530 754 5028
rbrebhun@ucdavis.edu |
| | |
Research Focus | The Biology and Therapy of Cancer Metastasis |
Specialty Focus | Comparative and Translational Oncology |
Education |
1995 BS Animal Science, Cornell University, Ithaca, NY
2002 DVM Veterinary Medicine, Cornell University, Ithaca, NY
2006 PhD Cancer Biology, UT Houston/M.D. Anderson Cancer Center, Houston, TX
2008 Residency Medical Oncology, Colorado State University, Fort Collins, CO
|
Honors and Awards |
2002 Pharmacia Veterinary Student Proficiency Award, Cornell University College of Veterinary Medicine
2002 Daphne Award for Clinical Proficiency and Excellence in the Practice of Veterinary Medicine, Cornell University College of Veterinary Medicine
2002 - 2006 Faculty/Alumni Merit Scholarship, University of Texas Houston/M.D. Anderson Cancer Center
2005 - 2006 American Legion Auxiliary Fellowship in Cancer Research, University of Texas Houston/M.D. Anderson Cancer Center
|
Licenses |
State Licensure - New York
State Licensure - Texas
State of Colorado, Academic License #47
Diplomate American College of Veterinary Internal Medicine (Oncology)
Certified in Good Clinical Practice (GCP)
|
Active Research Grants | Principal Investigator, The relationship between epidermal growth factor receptor and hedgehog signaling in colon cancer, (Principle Investigator), NIH NCRR Principal Investigator, Effects of fasting on the incidence of delayed-type chemotherapy induced nausea and vomiting in dogs receiving doxorubicin chemotherapy, (Principle Investigator), Center for Companion Animal Health Co-Investigator, Canine Cancer Stem Cell Initiative, Xinbin Chen (Principle Investigator), The Bernice Barbour Foundation Co-Investigator, C-Kit mutation and localization status as response predictors in canine mast cell tumors treated with toceranib or vinblastine, Douglas H. Thamm (Principle Investigator), The American Kennel Club Co-Investigator, Carboplatin Transcatheter Arterial Chemoembolization for the Treatment of Canine Nasal Tumors, Michele Steffey (Principle Investigator), Center for Companion Animal Health Principal Investigator, The effects of fluoroquinolone antibiotics on canine osteosarcoma cells., (Principle Investigator), Center for Companion Animal Health Co-Investigator, CHOP chemotherapy for Feline Lymphoma, Sara Frazier (Principle Investigator), Center for Companion Animal Health Co-Investigator, Evaluation of the Use of Chemoembolization in the Treatment of Prostatic Neoplasia, William Culp (Principle Investigator), Center for Companion Animal Health Co-Investigator, Adoptive immunotherapy in the dog: In-vitro proof of concept, Peter Moore (Principle Investigator), Center for Companion Animal Health |
Most Recent 10 Publications |  2011 Rebhun RB, Kent MS, Borrofka SA, Frazier S, Skorupski K, Rodriguez CO CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma Vet Comp Oncol,- 2010 Balhorn RL, Skorupski KA, Hok S, Balhorn MC, Guerrero T, Rebhun RB A selective high affinity ligand (SHAL) designed to bind to an over-expressed human antigen on non-Hodgkin's lymphoma also binds to canine B-cell lymphomas Vet Immunol Immunopathol,
- 2010 Rebhun RB, Cheng H, Gershenwald JE, Fan D, Fidler IJ, Langley RR Constitutive expression of the a4 integrin correlates with tumorigenicity and lymph node metastasis of the B16 murine melanoma Neoplasia,
- 2010 Rebhun RB, Thamm DH Multiple distinct malignancies in dogs: 53 cases J Am Anim Hosp Assoc,
- 2008 Rebhun RB, Lazar AJF, Fidler IJ, Gershenwald JE Impact of sentinel lymphadenectomy on survival in a murine model of melanoma Clin Exp Metastasis,
- 2008 Rebhun RB, Lana SE, Ehrhart EJ, Charles JB, Thamm DH Comparative analysis of survivin expression in untreated and relapsed canine lymphoma J Vet Intern Med,
- 2008 Sasaki T, Nakamura T, Rebhun RB, Cheng H, Hale KS, Tsan RZ, Fidler IJ, Langley RR Modification of the primary tumor microenvironment by transforming growth factor a-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model Am J Pathol,
- 2006 Rebhun RB, Langley RR, Yokoi K, Fan D, Gershenwald JE, Fidler IJ Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis Neoplasia,
- 2005 Thaker PH, Yokoi K, Jennings NB, Li Y, Rebhun RB, Rousseau DL, Fan D, Sood AK Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist nembutal Cancer Biol Ther,
- 2005 Yokoi K, Thaker PH, Yazici S, Rebhun RR, Nam DH, He J, Kim SJ, Abbruzzese JL, Hamilton SR, Fidler IJ Dual inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation by AEE788 reduces growth and metastasis of human colon carcinoma in an orthotopic nude mouse model Cancer Res,
|
Most Recent 5 Book Chapters | 2011 Rebhun RB, Culp W: Lung Cancer, Stephen J. Withrow, David M. Vail, Rodney Page, (ed),
Withrow & MacEwen's Small Animal Clinical Oncology. . |
